Barnard S D, Molello J A, Caldwell W J, Lebeau J E
Nouv Presse Med. 1980 Oct 30;9(40):3005-7.
The effects on rat liver of probucol (250 or 500 mg/kg/24 h), clofibrate (250 mg/kg/24 h) and fenofibrate (100 mg/kg/24 h) were compared after 28 days' treatment. Th bodyweight of animals treated with probucol 250 mg/kg/24 h has increased, as compared with a control group of untreated animals. The increase in liver weight and live weight/bodyweight ratio was greater in rats treated with clofibrate or fenofibrate than in rats treated with probucol. Cholesterol and triglyceride plasma levels were lower in clofibrate-treated animals. There were no changes in SGOT and SGPT in any of the three groups. Alkaline phosphatases were increased only in rats treated with clofibrate (these enzymes were not assayed in rats which received fenofibrate). Electron microscope study of liver sections showed the following changes in clofibrate--and fenofibrate-treated rats as compared with the control group: increase in smooth-surfaced endoplasmic reticulum, ribosome detachment, slight glycogen depletion and increase in the number of peroxysomes. In the probucol-treated group, apart from an occasional increase in smooth-surfaced endoplasmic reticulum, liver cells were identical with those of the control group; in particular, there was no increase in the number of peroxysomes.
在进行28天的治疗后,比较了普罗布考(250或500毫克/千克/24小时)、氯贝丁酯(250毫克/千克/24小时)和非诺贝特(100毫克/千克/24小时)对大鼠肝脏的影响。与未治疗的对照组动物相比,接受250毫克/千克/24小时普罗布考治疗的动物体重增加。接受氯贝丁酯或非诺贝特治疗的大鼠肝脏重量和肝脏重量/体重比的增加幅度大于接受普罗布考治疗的大鼠。氯贝丁酯治疗的动物血浆胆固醇和甘油三酯水平较低。三组中的任何一组血清谷草转氨酶(SGOT)和血清谷丙转氨酶(SGPT)均无变化。碱性磷酸酶仅在氯贝丁酯治疗的大鼠中升高(接受非诺贝特治疗的大鼠未检测这些酶)。肝脏切片的电子显微镜研究显示,与对照组相比,氯贝丁酯和非诺贝特治疗的大鼠有以下变化:滑面内质网增加、核糖体脱离、糖原轻度消耗和过氧化物酶体数量增加。在普罗布考治疗组中,除偶尔滑面内质网增加外,肝细胞与对照组相同;特别是,过氧化物酶体数量没有增加。